RANKL, OPG, and RUNX2 expression and epigenetic modifications in giant cell tumour of bone in 32 patients

The present study investigated receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG), and Runt-related transcription factor 2 (RUNX2) gene expressions in giant cell tumour of bone (GCTB) patients in relationship with tumour recurrence. We also aimed to investigate the in...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Bone & joint research 2024-02, Vol.13 (2), p.83-90
Hauptverfasser:	Amri, Raja, Chelly, Ameni, Ayedi, Mariem, Rebaii, Mohammed A, Aifa, Sami, Masmoudi, Sabeur, Keskes, Hassib
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!